12-15 Molecular Diagnostics
12-15 Molecular Diagnostics is an early-stage biotechnology company dedicated to revolutionizing testing and diagnostics with faster, more accurate, and affordable solutions. Their Veralize platform enables early detection of infections and chemical contaminants in fluids, including water, blood, saliva, and more, with results within 10 minutes. The company aims to improve public health, water quality, biodefense, and early disease detection through innovative nanotechnology and partnerships.
Industries
Nr. of Employees
small (1-50)
12-15 Molecular Diagnostics
Branford, Connecticut, United States, North America
Products
Portable nanotube‑based point‑of‑care diagnostic system
A portable diagnostic device using carbon‑nanotube sensor matrices encoded with sequence‑specific probes to detect pathogens or chemical contaminants in small fluid samples (saliva or water), providing results in under ~10 minutes.
Portable nanotube‑based point‑of‑care diagnostic system
A portable diagnostic device using carbon‑nanotube sensor matrices encoded with sequence‑specific probes to detect pathogens or chemical contaminants in small fluid samples (saliva or water), providing results in under ~10 minutes.
Services
Collaborative method validation with EPA‑approved water labs
Partnerships with EPA‑approved laboratories to validate water contaminant detection methods and support pathways to EPA approval.
Point‑of‑care diagnostic deployment for ambulatory settings
Provision and support of portable saliva‑based diagnostic systems intended for pharmacies, doctor offices, walk‑in clinics and pre‑operative screening.
Collaborative method validation with EPA‑approved water labs
Partnerships with EPA‑approved laboratories to validate water contaminant detection methods and support pathways to EPA approval.
Point‑of‑care diagnostic deployment for ambulatory settings
Provision and support of portable saliva‑based diagnostic systems intended for pharmacies, doctor offices, walk‑in clinics and pre‑operative screening.
Expertise Areas
- Point-of-care diagnostics
- Nanomaterials-based biosensor development
- Nucleic acid hybridization assays
- Water quality contaminant testing
Key Technologies
- Graphene / carbon nanotube sensor matrices
- Single‑stranded DNA/RNA hybridization assays
- Saliva‑based molecular diagnostics
- Portable point‑of‑care diagnostic hardware